非洲人类锥虫病的二胺类药物。

Mary F Paine, Michael Zhuo Wang, Claudia N Generaux, David W Boykin, W David Wilson, Harry P De Koning, Carol A Olson, Gabriele Pohlig, Christian Burri, Reto Brun, Grace A Murilla, John K Thuita, Michael P Barrett, Richard R Tidwell
{"title":"非洲人类锥虫病的二胺类药物。","authors":"Mary F Paine,&nbsp;Michael Zhuo Wang,&nbsp;Claudia N Generaux,&nbsp;David W Boykin,&nbsp;W David Wilson,&nbsp;Harry P De Koning,&nbsp;Carol A Olson,&nbsp;Gabriele Pohlig,&nbsp;Christian Burri,&nbsp;Reto Brun,&nbsp;Grace A Murilla,&nbsp;John K Thuita,&nbsp;Michael P Barrett,&nbsp;Richard R Tidwell","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Aromatic diamidines are potent trypanocides. Pentamidine, a diamidine, has been used for more than 60 years to treat human African trypanosomiasis (HAT); however, the drug must be administered parenterally and is active against first-stage HAT only, prior to the parasites causing neurological deterioration through invasion of the CNS. A major research effort to design novel diamidines has led to the development of orally active prodrugs and, remarkably, a new generation of compounds that can penetrate the CNS. In this review, progress in the development of diamidines for the treatment of HAT is discussed.</p>","PeriodicalId":10978,"journal":{"name":"Current opinion in investigational drugs","volume":"11 8","pages":"876-83"},"PeriodicalIF":0.0000,"publicationDate":"2010-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diamidines for human African trypanosomiasis.\",\"authors\":\"Mary F Paine,&nbsp;Michael Zhuo Wang,&nbsp;Claudia N Generaux,&nbsp;David W Boykin,&nbsp;W David Wilson,&nbsp;Harry P De Koning,&nbsp;Carol A Olson,&nbsp;Gabriele Pohlig,&nbsp;Christian Burri,&nbsp;Reto Brun,&nbsp;Grace A Murilla,&nbsp;John K Thuita,&nbsp;Michael P Barrett,&nbsp;Richard R Tidwell\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Aromatic diamidines are potent trypanocides. Pentamidine, a diamidine, has been used for more than 60 years to treat human African trypanosomiasis (HAT); however, the drug must be administered parenterally and is active against first-stage HAT only, prior to the parasites causing neurological deterioration through invasion of the CNS. A major research effort to design novel diamidines has led to the development of orally active prodrugs and, remarkably, a new generation of compounds that can penetrate the CNS. In this review, progress in the development of diamidines for the treatment of HAT is discussed.</p>\",\"PeriodicalId\":10978,\"journal\":{\"name\":\"Current opinion in investigational drugs\",\"volume\":\"11 8\",\"pages\":\"876-83\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current opinion in investigational drugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current opinion in investigational drugs","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

芳香二胺是有效的锥虫杀虫剂。喷他脒是一种二胺类药物,用于治疗非洲人类锥虫病已有60多年的历史;然而,该药物必须通过肠外给药,并且仅对第一阶段HAT有效,在寄生虫通过入侵中枢神经系统引起神经功能恶化之前。一项旨在设计新型二胺类药物的重大研究成果已经导致了口服活性前药的开发,值得注意的是,新一代化合物可以穿透中枢神经系统。本文就二胺类药物治疗HAT的研究进展作一综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Diamidines for human African trypanosomiasis.

Aromatic diamidines are potent trypanocides. Pentamidine, a diamidine, has been used for more than 60 years to treat human African trypanosomiasis (HAT); however, the drug must be administered parenterally and is active against first-stage HAT only, prior to the parasites causing neurological deterioration through invasion of the CNS. A major research effort to design novel diamidines has led to the development of orally active prodrugs and, remarkably, a new generation of compounds that can penetrate the CNS. In this review, progress in the development of diamidines for the treatment of HAT is discussed.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
>12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信